A vs TRDA · P/E 29, rev $1.88B vs P/E 12, rev $210.8M
Agilent Technologies Inc (A) versus Entrada Therapeutics Inc (TRDA) — a side-by-side from cached financials, not a winner call.
Agilent Technologies Inc (A) is a diagnostics & research company listed on US.
Entrada Therapeutics Inc (TRDA) is a biotechnology company listed on US.
Latest reported A revenue for 2026-07-31 was $1.88B. Net income was $362.0M. Revenue was up 2.3% from 2026-04-30 to 2026-07-31. A currently screens at market cap $33.70B and trailing P/E 29.2.
Latest reported TRDA revenue for 2024-12-31 was $210.8M. Net income was $65.6M. Revenue was up 63.4% from 2023-12-31 to 2024-12-31. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
A currently screens at market cap $33.70B and trailing P/E 29.2. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
Not investment advice. Open the A and TRDA stock pages for the full models.
Not investment advice.